188 related articles for article (PubMed ID: 24955377)
21. Cyclic Peptide Mimotopes for the Detection of Serum Anti-ATIC Autoantibody Biomarker in Hepato-Cellular Carcinoma.
Heo CK; Hwang HM; Lim WH; Lee HJ; Yoo JS; Lim KJ; Cho EW
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33352757
[TBL] [Abstract][Full Text] [Related]
22. Clinical utility of alpha fetoprotein and HCCR-1, alone or in combination, in patients with chronic hepatitis, liver cirrhosis and hepatocellular carcinoma.
Jirun P; Zhang G; Kim HK; Ha SA; Zhongtian J; Shishi Q; Zhuqingqing C; Lei G; Yoo J; Kim S; Park YG; Wang J; Yang Y; Xu Z; Huang Z; Lee YK; Song EY; Kim JW
Dis Markers; 2011; 30(6):307-15. PubMed ID: 21725159
[TBL] [Abstract][Full Text] [Related]
23. Development and potential application of a simultaneous multiplex assay of Golgi protein 73 and alpha-fetoprotein for hepatocellular carcinoma diagnosis.
Xiao J; Long F; Peng T; Hu LB; Cai H; Chen R; Chen WL
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3302-3310. PubMed ID: 31081083
[TBL] [Abstract][Full Text] [Related]
24. Expression of ADAM8 and its clinical values in diagnosis and prognosis of hepatocellular carcinoma.
Jiang C; Zhang Y; Yu HF; Yu XT; Zhou SJ; Tan YF
Tumour Biol; 2012 Dec; 33(6):2167-72. PubMed ID: 22941466
[TBL] [Abstract][Full Text] [Related]
25. Serum pentraxin 3 as a biomarker of hepatocellular carcinoma in chronic hepatitis B virus infection.
Deng H; Fan X; Wang X; Zeng L; Zhang K; Zhang X; Li N; Han Q; Lv Y; Liu Z
Sci Rep; 2020 Nov; 10(1):20276. PubMed ID: 33219288
[TBL] [Abstract][Full Text] [Related]
26. Early detection of hepatocellular carcinoma using autoantibody profiles from a panel of tumor-associated antigens.
Koziol JA; Imai H; Dai L; Zhang JY; Tan EM
Cancer Immunol Immunother; 2018 May; 67(5):835-841. PubMed ID: 29497780
[TBL] [Abstract][Full Text] [Related]
27. Six autoantibodies as potential serum biomarkers of hepatocellular carcinoma: A prospective multicenter study.
Okada R; Otsuka Y; Wakabayashi T; Shinoda M; Aoki T; Murakami M; Arizumi S; Yamamoto M; Aramaki O; Takayama T; Wakiyama S; Yanaga K; Amikura K; Kaneko H; Shimada H
Int J Cancer; 2020 Nov; 147(9):2578-2586. PubMed ID: 32574375
[TBL] [Abstract][Full Text] [Related]
28. Serum anti-Ku86 is a potential biomarker for early detection of hepatitis C virus-related hepatocellular carcinoma.
Nomura F; Sogawa K; Noda K; Seimiya M; Matsushita K; Miura T; Tomonaga T; Yoshitomi H; Imazeki F; Takizawa H; Mogushi K; Miyazaki M; Yokosuka O
Biochem Biophys Res Commun; 2012 May; 421(4):837-43. PubMed ID: 22554520
[TBL] [Abstract][Full Text] [Related]
29. Serum biomarkers for early detection of hepatocellular carcinoma associated with HCV infection in egyptian patients.
Zekri AR; Youssef AS; Bakr YM; Gabr RM; El-Rouby MN; Hammad I; Ahmed EA; Marzouk HA; Nabil MM; Hamed HA; Aly YH; Zachariah KS; Esmat G
Asian Pac J Cancer Prev; 2015; 16(3):1281-7. PubMed ID: 25735368
[TBL] [Abstract][Full Text] [Related]
30. Identification of beta2-microgloblin as a candidate for early diagnosis of imaging-invisible hepatocellular carcinoma in patient with liver cirrhosis.
Saito Y; Oba N; Nishinakagawa S; Mizuguchi Y; Kojima T; Nomura K; Nakatsura T
Oncol Rep; 2010 May; 23(5):1325-30. PubMed ID: 20372847
[TBL] [Abstract][Full Text] [Related]
31. Correlation between expression of p53, p21/WAF1, and MDM2 proteins and their prognostic significance in primary hepatocellular carcinoma.
Zhang MF; Zhang ZY; Fu J; Yang YF; Yun JP
J Transl Med; 2009 Dec; 7():110. PubMed ID: 20025780
[TBL] [Abstract][Full Text] [Related]
32. Biomarker discovery for early detection of hepatocellular carcinoma in hepatitis C-infected patients.
Mustafa MG; Petersen JR; Ju H; Cicalese L; Snyder N; Haidacher SJ; Denner L; Elferink C
Mol Cell Proteomics; 2013 Dec; 12(12):3640-52. PubMed ID: 24008390
[TBL] [Abstract][Full Text] [Related]
33. Change of circulating antibodies against CD25-derived peptide antigen in hepatocellular carcinoma.
Wang J; Xu Y; Zhao H; Zhang X
J Cancer Res Ther; 2017; 13(5):813-816. PubMed ID: 29237909
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic Value of Serum SMP30 and Anti-SMP30 Antibody in Hepatocellular Carcinoma.
Zheng SX; Xiang BD; Long JM; Qu C; Mo ZJ; Li K; Zhuang Y; Lv ZL; Zhou SF
Lab Med; 2018 Jul; 49(3):203-210. PubMed ID: 29562243
[TBL] [Abstract][Full Text] [Related]
35. Angiopoietin-like protein 3 and 4 expression 4 and their serum levels in hepatocellular carcinoma.
El-Shal AS; Zidan HE; Rashad NM; Wadea FM
Cytokine; 2017 Aug; 96():75-86. PubMed ID: 28371666
[TBL] [Abstract][Full Text] [Related]
36. Cancer-associated carbohydrate antigens as potential biomarkers for hepatocellular carcinoma.
Wu CS; Yen CJ; Chou RH; Li ST; Huang WC; Ren CT; Wu CY; Yu YL
PLoS One; 2012; 7(7):e39466. PubMed ID: 22808038
[TBL] [Abstract][Full Text] [Related]
37. Screening of autoantibodies as potential biomarkers for hepatocellular carcinoma by using T7 phase display system.
Liu H; Zhang J; Wang S; Pang Z; Wang Z; Zhou W; Wu M
Cancer Epidemiol; 2012 Feb; 36(1):82-8. PubMed ID: 22018955
[TBL] [Abstract][Full Text] [Related]
38. Increasing titers and changing specificities of antinuclear antibodies in patients with chronic liver disease who develop hepatocellular carcinoma.
Imai H; Nakano Y; Kiyosawa K; Tan EM
Cancer; 1993 Jan; 71(1):26-35. PubMed ID: 8380118
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancers.
Tangkijvanich P; Chanmee T; Komtong S; Mahachai V; Wisedopas N; Pothacharoen P; Kongtawelert P
J Gastroenterol Hepatol; 2010 Jan; 25(1):129-37. PubMed ID: 19793164
[TBL] [Abstract][Full Text] [Related]
40. An Analysis of Immunoreactive Signatures in Early Stage Hepatocellular Carcinoma.
Hong Y; Long J; Li H; Chen S; Liu Q; Zhang B; He X; Wang Y; Li H; Li Y; Zhang T; Lu C; Yan H; Zhang M; Li Q; Cao B; Bai Z; Wang J; Zhang Z; Zhu S; Zheng J; Ou X; Ma H; Jia J; You H; Wang S; Huang J
EBioMedicine; 2015 May; 2(5):438-46. PubMed ID: 26137588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
